Seroprevalence of Human Herpesvirus-8 in HIV-1 Infected and Uninfected Individuals in Cameroon

Overview

Journal Viruses

Publisher MDPI

Specialty Microbiology

Date 2013 Sep 24

PMID 24056671

Citations 7

Authors

Christelle Mbondji-Wonje

Viswanath Ragupathy

Sherwin Lee

Owen Wood

Bih Awazi

Indira K Hewlett

Affiliations

Soon will be listed here.

Abstract

We evaluated the prevalence of HHV-8 antibodies in 516 plasma samples collected from HIV positive and negative patients from blood banks and urban areas of Cameroon. Among HIV-1 positive samples, HHV-8 seropositivity rate was 61% based on combined reactivity using both ELISA and IFA techniques. HIV negative samples showed 62% seropositivity rate for HHV-8 antibodies. Our results indicate a high HHV-8 prevalence rate in both HIV infected and uninfected individuals in Cameroon.

Citing Articles

Relation between interleukin-6 concentrations and oxidative status of HIV infected patients with /or at risk of Kaposi disease in Yaounde.

Voufo R, Kouotou A, Tatah N, Teto G, Gueguim C, Ngonde C Virol J. 2023; 20(1):165.

PMID: 37491285 PMC: 10369812. DOI: 10.1186/s12985-023-02109-9.

Seroprevalence and molecular diversity of Human Herpesvirus 8 among people living with HIV in Brazzaville, Congo.

Malonga G, Jary A, Leducq V, Moudiongui Mboungou Malanda D, Boumba A, Chicaud E Sci Rep. 2021; 11(1):17442.

PMID: 34465868 PMC: 8408137. DOI: 10.1038/s41598-021-97070-4.

Human herpes virus 8 antibodies in HIV-positive patients in Surabaya, Indonesia.

Oktafiani D, Megasari N, Fitriana E, Nasronudin , Lusida M, Soetjipto Infect Dis Rep. 2020; 12(Suppl 1):8746.

PMID: 32874472 PMC: 7447943. DOI: 10.4081/idr.2020.8746.

HHV-8 Seroprevalence and Genotype Distribution in Africa, 1998⁻2017: A Systematic Review.

Etta E, Alayande D, Mavhandu-Ramarumo L, Gachara G, Bessong P Viruses. 2018; 10(9).

PMID: 30150604 PMC: 6164965. DOI: 10.3390/v10090458.

DETECTION OF HUMAN HERPESVIRUS-8 ANTIGEN IN HIV-INFECTED PATIENTS IN EAST JAVA, INDONESIA.

Oktafiani D, Megasari N, Fitriana E, Nasronudin , Lusida M, Soetjipto Afr J Infect Dis. 2018; 12(2):43-46.

PMID: 30109285 PMC: 6085735. DOI: 10.21010/ajid.v12i2.7.

References

Mocroft A, Kirk O, Clumeck N, Gargalianos-Kakolyris P, Trocha H, Chentsova N . The changing pattern of Kaposi sarcoma in patients with HIV, 1994-2003: the EuroSIDA Study. Cancer. 2004; 100(12):2644-54. DOI: 10.1002/cncr.20309. View

Duprez R, Kassa-Kelembho E, Plancoulaine S, Briere J, Fossi M, Kobangue L . Human herpesvirus 8 serological markers and viral load in patients with AIDS-associated Kaposi's sarcoma in Central African Republic. J Clin Microbiol. 2005; 43(9):4840-3. PMC: 1234088. DOI: 10.1128/JCM.43.9.4840-4843.2005. View

Klaskala W, Brayfield B, Kankasa C, Bhat G, West J, Mitchell C . Epidemiological characteristics of human herpesvirus-8 infection in a large population of antenatal women in Zambia. J Med Virol. 2004; 75(1):93-100. DOI: 10.1002/jmv.20242. View

Pellett P, Wright D, Engels E, Ablashi D, Dollard S, Forghani B . Multicenter comparison of serologic assays and estimation of human herpesvirus 8 seroprevalence among US blood donors. Transfusion. 2003; 43(9):1260-8. DOI: 10.1046/j.1537-2995.2003.00490.x. View

Gessain A, Mauclere P, van Beveren M, Plancoulaine S, Ayouba A, Martin P . Human herpesvirus 8 primary infection occurs during childhood in Cameroon, Central Africa. Int J Cancer. 1999; 81(2):189-92. DOI: 10.1002/(sici)1097-0215(19990412)81:2<189::aid-ijc4>3.0.co;2-e. View

Rezza G, Tchangmena O, Andreoni M, Bugarini R, Toma L, Bakary D . Prevalence and risk factors for human herpesvirus 8 infection in northern Cameroon. Sex Transm Dis. 2000; 27(3):159-64. DOI: 10.1097/00007435-200003000-00008. View

Viejo-Borbolla A, Ottinger M, Schulz T . Human herpesvirus 8: biology and role in the pathogenesis of Kaposi's sarcoma and other AIDS-related malignancies. Curr HIV/AIDS Rep. 2005; 1(1):5-11. DOI: 10.1007/s11904-004-0001-3. View

Pedergnana V, Gessain A, Tortevoye P, Byun M, Bacq-Daian D, Boland A . A major locus on chromosome 3p22 conferring predisposition to human herpesvirus 8 infection. Eur J Hum Genet. 2012; 20(6):690-5. PMC: 3355257. DOI: 10.1038/ejhg.2011.260. View

Adjei A, Armah H, Gbagbo F, Boamah I, Adu-Gyamfi C, Asare I . Seroprevalence of HHV-8, CMV, and EBV among the general population in Ghana, West Africa. BMC Infect Dis. 2008; 8:111. PMC: 2528010. DOI: 10.1186/1471-2334-8-111. View

10.

Ragupathy V, Zhao J, Wood O, Tang S, Lee S, Nyambi P . Identification of new, emerging HIV-1 unique recombinant forms and drug resistant viruses circulating in Cameroon. Virol J. 2011; 8:185. PMC: 3118203. DOI: 10.1186/1743-422X-8-185. View

11.

Ogoina D, Onyemelukwe G, Musa B, Babadoko A . Seroprevalence and determinants of human herpes virus 8 infection in adult Nigerians with and without HIV-1 infection. Afr Health Sci. 2011; 11(2):158-62. PMC: 3158522. View

12.

Bagni R, Whitby D . Kaposi's sarcoma-associated herpesvirus transmission and primary infection. Curr Opin HIV AIDS. 2009; 4(1):22-6. DOI: 10.1097/COH.0b013e32831add5a. View

13.

Dedicoat M, Newton R . Review of the distribution of Kaposi's sarcoma-associated herpesvirus (KSHV) in Africa in relation to the incidence of Kaposi's sarcoma. Br J Cancer. 2003; 88(1):1-3. PMC: 2376771. DOI: 10.1038/sj.bjc.6600745. View

14.

Zhao J, Tang S, Ragupathy V, Carr J, Wolfe N, Awazi B . Identification and genetic characterization of a novel CRF22_01A1 recombinant form of HIV type 1 in Cameroon. AIDS Res Hum Retroviruses. 2010; 26(9):1033-45. PMC: 2931544. DOI: 10.1089/aid.2009.0197. View

15.

Schatz O, Monini P, Bugarini R, Neipel F, Schulz T, Andreoni M . Kaposi's sarcoma-associated herpesvirus serology in Europe and Uganda: multicentre study with multiple and novel assays. J Med Virol. 2001; 65(1):123-32. View

16.

Pica F, Volpi A . Transmission of human herpesvirus 8: an update. Curr Opin Infect Dis. 2007; 20(2):152-6. DOI: 10.1097/QCO.0b013e3280143919. View

17.

Dukers N, Rezza G . Human herpesvirus 8 epidemiology: what we do and do not know. AIDS. 2003; 17(12):1717-30. DOI: 10.1097/01.aids.0000076337.42412.86. View

18.

Sasco A, Jaquet A, Boidin E, Ekouevi D, Thouillot F, Lemabec T . The challenge of AIDS-related malignancies in sub-Saharan Africa. PLoS One. 2010; 5(1):e8621. PMC: 2799672. DOI: 10.1371/journal.pone.0008621. View

19.

Cheung T . AIDS-related cancer in the era of highly active antiretroviral therapy (HAART): a model of the interplay of the immune system, virus, and cancer. "On the offensive--the Trojan Horse is being destroyed"--Part A: Kaposi's sarcoma. Cancer Invest. 2004; 22(5):774-86. DOI: 10.1081/cnv-200032788. View

20.

Edelman D, Ketema F, Saville R, Herman J, Sill A, Gill P . Specifics on the refinement and application of two serological assays for the detection of antibodies to HHV-8. J Clin Virol. 2000; 16(3):225-37. DOI: 10.1016/s1386-6532(99)00085-2. View